BioNTech and Bristol Myers Squibb will co-develop BNT327 for solid tumors in a $1.5 billion deal with potential milestones ...

By Michael Erman and Ludwig Burger (Reuters) -Bristol Myers Squibb has agreed to pay up to $11.1 billion in a partnership ...

Sean Gallup / Getty Images BioNTech's U.S.-listed shares surged more than 15% Monday morning after the company said it will partner with Bristol Myers Squibb. The companies will co-develop a drug ...